Skip to main content

Emapalumab

Generic name: emapalumab [ EM-a-PAL-ue-mab ]
Brand name: Gamifant
Dosage form: intravenous solution (lzsg 5 mg/mL)
Drug class: Selective immunosuppressants

Medically reviewed by Drugs.com on Jul 22, 2024. Written by Cerner Multum.

What is emapalumab?

Emapalumab is used together with a medicine called dexamethasone to treat hemophagocytic lymphohistiocytosis (HLH), a rare disease that is sometimes inherited. HLH causes your immune system to attack healthy blood cells, which can lead to serious or life-threatening side effects on your spleen or liver. Emapalumab is for use in adults and children as young as newborn.

Emapalumab is given after other treatments did not work or have stopped working.

Emapalumab may also be used for purposes not listed in this medication guide.

Emapalumab side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Some side effects may occur during the injection. Tell your caregiver if you feel feverish, chilled, sweaty, itchy, light-headed, nauseated, or if you have chest pain, shortness of breath, or skin rash or redness.

You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:

Common side effects of emapalumab may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Warnings

Emapalumab affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, night sweats, skin sores, cough, trouble breathing, or cough with bloody mucus.

Before taking this medicine

Tell your doctor if you have ever had tuberculosis or if anyone in your household has tuberculosis. Also tell your doctor if you have recently traveled. Tuberculosis and some fungal infections are more common in certain parts of the world, and you may have been exposed during travel.

Tell your doctor if you have ever had:

Tell your doctor if you are pregnant or breastfeeding.

How is emapalumab given?

Before you start treatment with emapalumab, your doctor may perform tests to make sure you do not have tuberculosis or other infections.

Emapalumab is given as an infusion into a vein, usually once every 3 or 4 days. A healthcare provider will give you this injection.

emapalumab must be given slowly, and the infusion can take about 1 hour to complete.

Emapalumab affects your immune system. You may get infections more easily, even serious or fatal infections. You will need blood tests to help your doctor determine how long to treat you with this medicine.

You may be given other medications to help prevent serious infections. Keep using these medicines for as long as your doctor has prescribed.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment for your emapalumab injection.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while receiving emapalumab?

Do not receive a "live" vaccine while using emapalumab and for at least 4 weeks after your last dose. Live vaccines include measles, mumps, rubella (MMR), polio, rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine.

What other drugs will affect emapalumab?

Other drugs may affect emapalumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Does emapalumab interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Emapalumab Biosimilars

Biosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product.

Reference products

These are biological products that have already been approved by the FDA, against which biosimilar products are compared. There is 1 for emapalumab.

Gamifant (emapalumab-lzsg) - Swedish Orphan Biovitrum AB (publ)
Formulation type Strength
Single-Dose Vial 100 mg/20 mL (5 mg/mL)
Single-Dose Vial 10 mg/2 mL (5 mg/mL)
Single-Dose Vial 50 mg/10 mL (5 mg/mL)

View Gamifant information in detail.

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.